moxisylyte has been researched along with Corneal Diseases in 1 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Corneal Diseases: Diseases of the cornea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Norden, LC | 1 |
1 other study available for moxisylyte and Corneal Diseases
| Article | Year |
|---|---|
Adverse reactions to topical ocular autonomic agents.
Topics: Atropine; Autonomic Agents; Corneal Diseases; Cyclopentolate; Drug Hypersensitivity; Glaucoma; Human | 1978 |